Global GABA (CAS 56-12-2) Market Insights, Forecast to 2026
GABA (?-aminobutyric acid) is a four carbon non-protein amino acid that is widely distributed in plants, animals and microorganisms. As a metabolic product of plants and microorganisms produced by the decarboxylation of glutamic acid, GABA functions as an inhibitory neurotransmitter in the brain that directly affects the personality and the stress management. A wide range of traditional foods produced by microbial fermentation contain GABA, in which GABA is safe and eco-friendly, and also has the possibility of providing new health-benefited products enriched with GABA. Synthesis of GABA is catalyzed by glutamate decarboxylase, therefore, the optimal fermentation condition is mainly based on the biochemical properties of the enzyme. Major GABA producing microorganisms are lactic acid bacteria (LAB), which make food spoilage pathogens unable to grow and act as probiotics in the gastrointestinal tract.
Gamma-Amino Butyric acid (GABA) is an amino acid which acts as a neurotransmitter in the central nervous system. It inhibits nerve transmission in the brain, calming nervous activity. GABA plays an important role in behavior, cognition, and the body's response to stress. Lower-than-normal levels of GABA in the brain have been linked to schizophrenia, depression, anxiety, and sleep disorders.
At present, there are two ways to produce GABA: chemical synthesis method and biological fermentation method. Among them, biological fermentation method feeding on monosodium L-glutamate and Lactobacillus, is safer and more widely used. Only in this way, can GABA be used in pharmaceuticals, foods, beverages, and animal feeds in China. The price of GABA produced from monosodium L-glutamate and Lactobacillus is relatively higher. As the limitation of application fields, the market share of chemical synthesis product decreased
Since the COVID-19 virus outbreak in December 2019, the disease has spread to almost 100 countries around the globe with the World Health Organization declaring it a public health emergency. The global impacts of the coronavirus disease 2019 (COVID-19) are already starting to be felt, and will significantly affect the GABA (CAS 56-12-2) 3900 market in 2020.
COVID-19 can affect the global economy in three main ways: by directly affecting production and demand, by creating supply chain and market disruption, and by its financial impact on firms and financial markets.
The outbreak of COVID-19 has brought effects on many aspects, like flight cancellations; travel bans and quarantines; restaurants closed; all indoor events restricted; over forty countries state of emergency declared; massive slowing of the supply chain; stock market volatility; falling business confidence, growing panic among the population, and uncertainty about future.
This report also analyses the impact of Coronavirus COVID-19 on the GABA (CAS 56-12-2) 3900 industry.
Based on our recent survey, we have several different scenarios about the GABA (CAS 56-12-2) 3900 YoY growth rate for 2020. The probable scenario is expected to grow by a xx% in 2020 and the revenue will be xx in 2020 from US$ 47 million in 2019. The market size of GABA (CAS 56-12-2) 3900 will reach xx in 2026, with a CAGR of xx% from 2020 to 2026.
With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global GABA (CAS 56-12-2) market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global GABA (CAS 56-12-2) market in terms of both revenue and volume.
Players, stakeholders, and other participants in the global GABA (CAS 56-12-2) market will be able to gain the upper hand as they use the report as a powerful resource. For this version of the report, the segmental analysis focuses on sales (volume), revenue and forecast by each application segment in terms of sales and revenue and forecast by each type segment in terms of revenue for the period 2015-2026.
Sales and Pricing Analyses
Readers are provided with deeper sales analysis and pricing analysis for the global GABA (CAS 56-12-2) market. As part of sales analysis, the report offers accurate statistics and figures for sales and revenue by region, by each type segment for the period 2015-2026.
In the pricing analysis section of the report, readers are provided with validated statistics and figures for the price by players and price by region for the period 2015-2020 and price by each type segment for the period 2015-2020.
Regional and Country-level Analysis
The report offers an exhaustive geographical analysis of the global GABA (CAS 56-12-2) market, covering important regions, viz, North America, Europe, China and Japan. It also covers key countries (regions), viz, U.S., Canada, Germany, France, U.K., Italy, Russia, China, Japan, South Korea, India, Australia, Taiwan, Indonesia, Thailand, Malaysia, Philippines, Vietnam, Mexico, Brazil, Turkey, Saudi Arabia, UAE, etc.
The report includes country-wise and region-wise market size for the period 2015-2026. It also includes market size and forecast by each application segment in terms of sales for the period 2015-2026.
Competition Analysis
In the competitive analysis section of the report, leading as well as prominent players of the global GABA (CAS 56-12-2) market are broadly studied on the basis of key factors. The report offers comprehensive analysis and accurate statistics on sales by the player for the period 2015-2020. It also offers detailed analysis supported by reliable statistics on price and revenue (global level) by player for the period 2015-2020.
On the whole, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global GABA (CAS 56-12-2) market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global GABA (CAS 56-12-2) market.
The following manufacturers are covered in this report:
Gamma-Amino Butyric acid (GABA) is an amino acid which acts as a neurotransmitter in the central nervous system. It inhibits nerve transmission in the brain, calming nervous activity. GABA plays an important role in behavior, cognition, and the body's response to stress. Lower-than-normal levels of GABA in the brain have been linked to schizophrenia, depression, anxiety, and sleep disorders.
At present, there are two ways to produce GABA: chemical synthesis method and biological fermentation method. Among them, biological fermentation method feeding on monosodium L-glutamate and Lactobacillus, is safer and more widely used. Only in this way, can GABA be used in pharmaceuticals, foods, beverages, and animal feeds in China. The price of GABA produced from monosodium L-glutamate and Lactobacillus is relatively higher. As the limitation of application fields, the market share of chemical synthesis product decreased
Since the COVID-19 virus outbreak in December 2019, the disease has spread to almost 100 countries around the globe with the World Health Organization declaring it a public health emergency. The global impacts of the coronavirus disease 2019 (COVID-19) are already starting to be felt, and will significantly affect the GABA (CAS 56-12-2) 3900 market in 2020.
COVID-19 can affect the global economy in three main ways: by directly affecting production and demand, by creating supply chain and market disruption, and by its financial impact on firms and financial markets.
The outbreak of COVID-19 has brought effects on many aspects, like flight cancellations; travel bans and quarantines; restaurants closed; all indoor events restricted; over forty countries state of emergency declared; massive slowing of the supply chain; stock market volatility; falling business confidence, growing panic among the population, and uncertainty about future.
This report also analyses the impact of Coronavirus COVID-19 on the GABA (CAS 56-12-2) 3900 industry.
Based on our recent survey, we have several different scenarios about the GABA (CAS 56-12-2) 3900 YoY growth rate for 2020. The probable scenario is expected to grow by a xx% in 2020 and the revenue will be xx in 2020 from US$ 47 million in 2019. The market size of GABA (CAS 56-12-2) 3900 will reach xx in 2026, with a CAGR of xx% from 2020 to 2026.
With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global GABA (CAS 56-12-2) market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global GABA (CAS 56-12-2) market in terms of both revenue and volume.
Players, stakeholders, and other participants in the global GABA (CAS 56-12-2) market will be able to gain the upper hand as they use the report as a powerful resource. For this version of the report, the segmental analysis focuses on sales (volume), revenue and forecast by each application segment in terms of sales and revenue and forecast by each type segment in terms of revenue for the period 2015-2026.
Sales and Pricing Analyses
Readers are provided with deeper sales analysis and pricing analysis for the global GABA (CAS 56-12-2) market. As part of sales analysis, the report offers accurate statistics and figures for sales and revenue by region, by each type segment for the period 2015-2026.
In the pricing analysis section of the report, readers are provided with validated statistics and figures for the price by players and price by region for the period 2015-2020 and price by each type segment for the period 2015-2020.
Regional and Country-level Analysis
The report offers an exhaustive geographical analysis of the global GABA (CAS 56-12-2) market, covering important regions, viz, North America, Europe, China and Japan. It also covers key countries (regions), viz, U.S., Canada, Germany, France, U.K., Italy, Russia, China, Japan, South Korea, India, Australia, Taiwan, Indonesia, Thailand, Malaysia, Philippines, Vietnam, Mexico, Brazil, Turkey, Saudi Arabia, UAE, etc.
The report includes country-wise and region-wise market size for the period 2015-2026. It also includes market size and forecast by each application segment in terms of sales for the period 2015-2026.
Competition Analysis
In the competitive analysis section of the report, leading as well as prominent players of the global GABA (CAS 56-12-2) market are broadly studied on the basis of key factors. The report offers comprehensive analysis and accurate statistics on sales by the player for the period 2015-2020. It also offers detailed analysis supported by reliable statistics on price and revenue (global level) by player for the period 2015-2020.
On the whole, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global GABA (CAS 56-12-2) market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global GABA (CAS 56-12-2) market.
The following manufacturers are covered in this report:
- Pharma Foods International
- Sekisui Chemical
- Zhejiang YiWan Biolabs
- Shanghai Richen
- Guangdong Luckerkong Biotech
- Tianjin Shijitianlong Biotech
- Ningxiang Jiayuan Biology Technology
- Zhejiang Tianrui Chemical
- Taizhou Xinyou Pharmaceutical & Chemical
- Chemical Synthesis
- Biological Fermentation
- Pharmaceuticals
- Food & Beverage
- Animal Feeds
- Others
1 STUDY COVERAGE
1.1 GABA (CAS 56-12-2) Product Introduction
1.2 Market Segments
1.3 Key GABA (CAS 56-12-2) Manufacturers Covered: Ranking by Revenue
1.4 Market by Type
1.4.1 Global GABA (CAS 56-12-2) Market Size Growth Rate by Type
1.4.2 Chemical Synthesis
1.4.3 Biological Fermentation
1.5 Market by Application
1.5.1 Global GABA (CAS 56-12-2) Market Size Growth Rate by Application
1.5.2 Pharmaceuticals
1.5.3 Food & Beverage
1.5.4 Animal Feeds
1.5.5 Others
1.6 Coronavirus Disease 2019 (Covid-19): GABA (CAS 56-12-2) Industry Impact
1.6.1 How the Covid-19 is Affecting the GABA (CAS 56-12-2) Industry
1.6.1.1 GABA (CAS 56-12-2) Business Impact Assessment - Covid-19
1.6.1.2 Supply Chain Challenges
1.6.1.3 COVID-19’s Impact On Crude Oil and Refined Products
1.6.2 Market Trends and GABA (CAS 56-12-2) Potential Opportunities in the COVID-19 Landscape
1.6.3 Measures / Proposal against Covid-19
1.6.3.1 Government Measures to Combat Covid-19 Impact
1.6.3.2 Proposal for GABA (CAS 56-12-2) Players to Combat Covid-19 Impact
1.7 Study Objectives
1.8 Years Considered
2 EXECUTIVE SUMMARY
2.1 Global GABA (CAS 56-12-2) Market Size Estimates and Forecasts
2.1.1 Global GABA (CAS 56-12-2) Revenue 2015-2026
2.1.2 Global GABA (CAS 56-12-2) Sales 2015-2026
2.2 GABA (CAS 56-12-2) Market Size by Region: 2020 Versus 2026
2.2.1 Global GABA (CAS 56-12-2) Retrospective Market Scenario in Sales by Region: 2015-2020
2.2.2 Global GABA (CAS 56-12-2) Retrospective Market Scenario in Revenue by Region: 2015-2020
3 GLOBAL GABA (CAS 56-12-2) COMPETITOR LANDSCAPE BY PLAYERS
3.1 GABA (CAS 56-12-2) Sales by Manufacturers
3.1.1 GABA (CAS 56-12-2) Sales by Manufacturers (2015-2020)
3.1.2 GABA (CAS 56-12-2) Sales Market Share by Manufacturers (2015-2020)
3.2 GABA (CAS 56-12-2) Revenue by Manufacturers
3.2.1 GABA (CAS 56-12-2) Revenue by Manufacturers (2015-2020)
3.2.2 GABA (CAS 56-12-2) Revenue Share by Manufacturers (2015-2020)
3.2.3 Global GABA (CAS 56-12-2) Market Concentration Ratio (CR5 and HHI) (2015-2020)
3.2.4 Global Top 10 and Top 5 Companies by GABA (CAS 56-12-2) Revenue in 2019
3.2.5 Global GABA (CAS 56-12-2) Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 GABA (CAS 56-12-2) Price by Manufacturers
3.4 GABA (CAS 56-12-2) Manufacturing Base Distribution, Product Types
3.4.1 GABA (CAS 56-12-2) Manufacturers Manufacturing Base Distribution, Headquarters
3.4.2 Manufacturers GABA (CAS 56-12-2) Product Type
3.4.3 Date of International Manufacturers Enter into GABA (CAS 56-12-2) Market
3.5 Manufacturers Mergers & Acquisitions, Expansion Plans
4 BREAKDOWN DATA BY TYPE (2015-2026)
4.1 Global GABA (CAS 56-12-2) Market Size by Type (2015-2020)
4.1.1 Global GABA (CAS 56-12-2) Sales by Type (2015-2020)
4.1.2 Global GABA (CAS 56-12-2) Revenue by Type (2015-2020)
4.1.3 GABA (CAS 56-12-2) Average Selling Price (ASP) by Type (2015-2026)
4.2 Global GABA (CAS 56-12-2) Market Size Forecast by Type (2021-2026)
4.2.1 Global GABA (CAS 56-12-2) Sales Forecast by Type (2021-2026)
4.2.2 Global GABA (CAS 56-12-2) Revenue Forecast by Type (2021-2026)
4.2.3 GABA (CAS 56-12-2) Average Selling Price (ASP) Forecast by Type (2021-2026)
4.3 Global GABA (CAS 56-12-2) Market Share by Price Tier (2015-2020): Low-End, Mid-Range and High-End
5 BREAKDOWN DATA BY APPLICATION (2015-2026)
5.1 Global GABA (CAS 56-12-2) Market Size by Application (2015-2020)
5.1.1 Global GABA (CAS 56-12-2) Sales by Application (2015-2020)
5.1.2 Global GABA (CAS 56-12-2) Revenue by Application (2015-2020)
5.1.3 GABA (CAS 56-12-2) Price by Application (2015-2020)
5.2 GABA (CAS 56-12-2) Market Size Forecast by Application (2021-2026)
5.2.1 Global GABA (CAS 56-12-2) Sales Forecast by Application (2021-2026)
5.2.2 Global GABA (CAS 56-12-2) Revenue Forecast by Application (2021-2026)
5.2.3 Global GABA (CAS 56-12-2) Price Forecast by Application (2021-2026)
6 NORTH AMERICA
6.1 North America GABA (CAS 56-12-2) by Country
6.1.1 North America GABA (CAS 56-12-2) Sales by Country
6.1.2 North America GABA (CAS 56-12-2) Revenue by Country
6.1.3 U.S.
6.1.4 Canada
6.2 North America GABA (CAS 56-12-2) Market Facts & Figures by Type
6.3 North America GABA (CAS 56-12-2) Market Facts & Figures by Application
7 EUROPE
7.1 Europe GABA (CAS 56-12-2) by Country
7.1.1 Europe GABA (CAS 56-12-2) Sales by Country
7.1.2 Europe GABA (CAS 56-12-2) Revenue by Country
7.1.3 Germany
7.1.4 France
7.1.5 U.K.
7.1.6 Italy
7.1.7 Russia
7.2 Europe GABA (CAS 56-12-2) Market Facts & Figures by Type
7.3 Europe GABA (CAS 56-12-2) Market Facts & Figures by Application
8 ASIA PACIFIC
8.1 Asia Pacific GABA (CAS 56-12-2) by Region
8.1.1 Asia Pacific GABA (CAS 56-12-2) Sales by Region
8.1.2 Asia Pacific GABA (CAS 56-12-2) Revenue by Region
8.1.3 China
8.1.4 Japan
8.1.5 South Korea
8.1.6 India
8.1.7 Australia
8.1.8 Taiwan
8.1.9 Indonesia
8.1.10 Thailand
8.1.11 Malaysia
8.1.12 Philippines
8.1.13 Vietnam
8.2 Asia Pacific GABA (CAS 56-12-2) Market Facts & Figures by Type
8.3 Asia Pacific GABA (CAS 56-12-2) Market Facts & Figures by Application
9 LATIN AMERICA
9.1 Latin America GABA (CAS 56-12-2) by Country
9.1.1 Latin America GABA (CAS 56-12-2) Sales by Country
9.1.2 Latin America GABA (CAS 56-12-2) Revenue by Country
9.1.3 Mexico
9.1.4 Brazil
9.1.5 Argentina
9.2 Central & South America GABA (CAS 56-12-2) Market Facts & Figures by Type
9.3 Central & South America GABA (CAS 56-12-2) Market Facts & Figures by Application
10 MIDDLE EAST AND AFRICA
10.1 Middle East and Africa GABA (CAS 56-12-2) by Country
10.1.1 Middle East and Africa GABA (CAS 56-12-2) Sales by Country
10.1.2 Middle East and Africa GABA (CAS 56-12-2) Revenue by Country
10.1.3 Turkey
10.1.4 Saudi Arabia
10.1.5 UAE
10.2 Middle East and Africa GABA (CAS 56-12-2) Market Facts & Figures by Type
10.3 Middle East and Africa GABA (CAS 56-12-2) Market Facts & Figures by Application
11 COMPANY PROFILES
11.1 Pharma Foods International
11.1.1 Pharma Foods International Corporation Information
11.1.2 Pharma Foods International Description, Business Overview and Total Revenue
11.1.3 Pharma Foods International Sales, Revenue and Gross Margin (2015-2020)
11.1.4 Pharma Foods International GABA (CAS 56-12-2) Products Offered
11.1.5 Pharma Foods International Recent Development
11.2 Sekisui Chemical
11.2.1 Sekisui Chemical Corporation Information
11.2.2 Sekisui Chemical Description, Business Overview and Total Revenue
11.2.3 Sekisui Chemical Sales, Revenue and Gross Margin (2015-2020)
11.2.4 Sekisui Chemical GABA (CAS 56-12-2) Products Offered
11.2.5 Sekisui Chemical Recent Development
11.3 Zhejiang YiWan Biolabs
11.3.1 Zhejiang YiWan Biolabs Corporation Information
11.3.2 Zhejiang YiWan Biolabs Description, Business Overview and Total Revenue
11.3.3 Zhejiang YiWan Biolabs Sales, Revenue and Gross Margin (2015-2020)
11.3.4 Zhejiang YiWan Biolabs GABA (CAS 56-12-2) Products Offered
11.3.5 Zhejiang YiWan Biolabs Recent Development
11.4 Shanghai Richen
11.4.1 Shanghai Richen Corporation Information
11.4.2 Shanghai Richen Description, Business Overview and Total Revenue
11.4.3 Shanghai Richen Sales, Revenue and Gross Margin (2015-2020)
11.4.4 Shanghai Richen GABA (CAS 56-12-2) Products Offered
11.4.5 Shanghai Richen Recent Development
11.5 Guangdong Luckerkong Biotech
11.5.1 Guangdong Luckerkong Biotech Corporation Information
11.5.2 Guangdong Luckerkong Biotech Description, Business Overview and Total Revenue
11.5.3 Guangdong Luckerkong Biotech Sales, Revenue and Gross Margin (2015-2020)
11.5.4 Guangdong Luckerkong Biotech GABA (CAS 56-12-2) Products Offered
11.5.5 Guangdong Luckerkong Biotech Recent Development
11.6 Tianjin Shijitianlong Biotech
11.6.1 Tianjin Shijitianlong Biotech Corporation Information
11.6.2 Tianjin Shijitianlong Biotech Description, Business Overview and Total Revenue
11.6.3 Tianjin Shijitianlong Biotech Sales, Revenue and Gross Margin (2015-2020)
11.6.4 Tianjin Shijitianlong Biotech GABA (CAS 56-12-2) Products Offered
11.6.5 Tianjin Shijitianlong Biotech Recent Development
11.7 Ningxiang Jiayuan Biology Technology
11.7.1 Ningxiang Jiayuan Biology Technology Corporation Information
11.7.2 Ningxiang Jiayuan Biology Technology Description, Business Overview and Total Revenue
11.7.3 Ningxiang Jiayuan Biology Technology Sales, Revenue and Gross Margin (2015-2020)
11.7.4 Ningxiang Jiayuan Biology Technology GABA (CAS 56-12-2) Products Offered
11.7.5 Ningxiang Jiayuan Biology Technology Recent Development
11.8 Zhejiang Tianrui Chemical
11.8.1 Zhejiang Tianrui Chemical Corporation Information
11.8.2 Zhejiang Tianrui Chemical Description, Business Overview and Total Revenue
11.8.3 Zhejiang Tianrui Chemical Sales, Revenue and Gross Margin (2015-2020)
11.8.4 Zhejiang Tianrui Chemical GABA (CAS 56-12-2) Products Offered
11.8.5 Zhejiang Tianrui Chemical Recent Development
11.9 Taizhou Xinyou Pharmaceutical & Chemical
11.9.1 Taizhou Xinyou Pharmaceutical & Chemical Corporation Information
11.9.2 Taizhou Xinyou Pharmaceutical & Chemical Description, Business Overview and Total Revenue
11.9.3 Taizhou Xinyou Pharmaceutical & Chemical Sales, Revenue and Gross Margin (2015-2020)
11.9.4 Taizhou Xinyou Pharmaceutical & Chemical GABA (CAS 56-12-2) Products Offered
11.9.5 Taizhou Xinyou Pharmaceutical & Chemical Recent Development
11.1 Pharma Foods International
11.1.1 Pharma Foods International Corporation Information
11.1.2 Pharma Foods International Description, Business Overview and Total Revenue
11.1.3 Pharma Foods International Sales, Revenue and Gross Margin (2015-2020)
11.1.4 Pharma Foods International GABA (CAS 56-12-2) Products Offered
11.1.5 Pharma Foods International Recent Development
12 FUTURE FORECAST BY REGIONS (COUNTRIES) (2021-2026)
12.1 GABA (CAS 56-12-2) Market Estimates and Projections by Region
12.1.1 Global GABA (CAS 56-12-2) Sales Forecast by Regions 2021-2026
12.1.2 Global GABA (CAS 56-12-2) Revenue Forecast by Regions 2021-2026
12.2 North America GABA (CAS 56-12-2) Market Size Forecast (2021-2026)
12.2.1 North America: GABA (CAS 56-12-2) Sales Forecast (2021-2026)
12.2.2 North America: GABA (CAS 56-12-2) Revenue Forecast (2021-2026)
12.2.3 North America: GABA (CAS 56-12-2) Market Size Forecast by Country (2021-2026)
12.3 Europe GABA (CAS 56-12-2) Market Size Forecast (2021-2026)
12.3.1 Europe: GABA (CAS 56-12-2) Sales Forecast (2021-2026)
12.3.2 Europe: GABA (CAS 56-12-2) Revenue Forecast (2021-2026)
12.3.3 Europe: GABA (CAS 56-12-2) Market Size Forecast by Country (2021-2026)
12.4 Asia Pacific GABA (CAS 56-12-2) Market Size Forecast (2021-2026)
12.4.1 Asia Pacific: GABA (CAS 56-12-2) Sales Forecast (2021-2026)
12.4.2 Asia Pacific: GABA (CAS 56-12-2) Revenue Forecast (2021-2026)
12.4.3 Asia Pacific: GABA (CAS 56-12-2) Market Size Forecast by Region (2021-2026)
12.5 Latin America GABA (CAS 56-12-2) Market Size Forecast (2021-2026)
12.5.1 Latin America: GABA (CAS 56-12-2) Sales Forecast (2021-2026)
12.5.2 Latin America: GABA (CAS 56-12-2) Revenue Forecast (2021-2026)
12.5.3 Latin America: GABA (CAS 56-12-2) Market Size Forecast by Country (2021-2026)
12.6 Middle East and Africa GABA (CAS 56-12-2) Market Size Forecast (2021-2026)
12.6.1 Middle East and Africa: GABA (CAS 56-12-2) Sales Forecast (2021-2026)
12.6.2 Middle East and Africa: GABA (CAS 56-12-2) Revenue Forecast (2021-2026)
12.6.3 Middle East and Africa: GABA (CAS 56-12-2) Market Size Forecast by Country (2021-2026)
13 MARKET OPPORTUNITIES, CHALLENGES, RISKS AND INFLUENCES FACTORS ANALYSIS
13.1 Market Opportunities and Drivers
13.2 Market Challenges
13.3 Market Risks/Restraints
13.4 Porter’s Five Forces Analysis
13.5 Primary Interviews with Key GABA (CAS 56-12-2) Players (Opinion Leaders)
14 VALUE CHAIN AND SALES CHANNELS ANALYSIS
14.1 Value Chain Analysis
14.2 GABA (CAS 56-12-2) Customers
14.3 Sales Channels Analysis
14.3.1 Sales Channels
14.3.2 Distributors
15 RESEARCH FINDINGS AND CONCLUSION
16 APPENDIX
16.1 Research Methodology
16.1.1 Methodology/Research Approach
16.1.2 Data Source
16.2 Author Details
1.1 GABA (CAS 56-12-2) Product Introduction
1.2 Market Segments
1.3 Key GABA (CAS 56-12-2) Manufacturers Covered: Ranking by Revenue
1.4 Market by Type
1.4.1 Global GABA (CAS 56-12-2) Market Size Growth Rate by Type
1.4.2 Chemical Synthesis
1.4.3 Biological Fermentation
1.5 Market by Application
1.5.1 Global GABA (CAS 56-12-2) Market Size Growth Rate by Application
1.5.2 Pharmaceuticals
1.5.3 Food & Beverage
1.5.4 Animal Feeds
1.5.5 Others
1.6 Coronavirus Disease 2019 (Covid-19): GABA (CAS 56-12-2) Industry Impact
1.6.1 How the Covid-19 is Affecting the GABA (CAS 56-12-2) Industry
1.6.1.1 GABA (CAS 56-12-2) Business Impact Assessment - Covid-19
1.6.1.2 Supply Chain Challenges
1.6.1.3 COVID-19’s Impact On Crude Oil and Refined Products
1.6.2 Market Trends and GABA (CAS 56-12-2) Potential Opportunities in the COVID-19 Landscape
1.6.3 Measures / Proposal against Covid-19
1.6.3.1 Government Measures to Combat Covid-19 Impact
1.6.3.2 Proposal for GABA (CAS 56-12-2) Players to Combat Covid-19 Impact
1.7 Study Objectives
1.8 Years Considered
2 EXECUTIVE SUMMARY
2.1 Global GABA (CAS 56-12-2) Market Size Estimates and Forecasts
2.1.1 Global GABA (CAS 56-12-2) Revenue 2015-2026
2.1.2 Global GABA (CAS 56-12-2) Sales 2015-2026
2.2 GABA (CAS 56-12-2) Market Size by Region: 2020 Versus 2026
2.2.1 Global GABA (CAS 56-12-2) Retrospective Market Scenario in Sales by Region: 2015-2020
2.2.2 Global GABA (CAS 56-12-2) Retrospective Market Scenario in Revenue by Region: 2015-2020
3 GLOBAL GABA (CAS 56-12-2) COMPETITOR LANDSCAPE BY PLAYERS
3.1 GABA (CAS 56-12-2) Sales by Manufacturers
3.1.1 GABA (CAS 56-12-2) Sales by Manufacturers (2015-2020)
3.1.2 GABA (CAS 56-12-2) Sales Market Share by Manufacturers (2015-2020)
3.2 GABA (CAS 56-12-2) Revenue by Manufacturers
3.2.1 GABA (CAS 56-12-2) Revenue by Manufacturers (2015-2020)
3.2.2 GABA (CAS 56-12-2) Revenue Share by Manufacturers (2015-2020)
3.2.3 Global GABA (CAS 56-12-2) Market Concentration Ratio (CR5 and HHI) (2015-2020)
3.2.4 Global Top 10 and Top 5 Companies by GABA (CAS 56-12-2) Revenue in 2019
3.2.5 Global GABA (CAS 56-12-2) Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 GABA (CAS 56-12-2) Price by Manufacturers
3.4 GABA (CAS 56-12-2) Manufacturing Base Distribution, Product Types
3.4.1 GABA (CAS 56-12-2) Manufacturers Manufacturing Base Distribution, Headquarters
3.4.2 Manufacturers GABA (CAS 56-12-2) Product Type
3.4.3 Date of International Manufacturers Enter into GABA (CAS 56-12-2) Market
3.5 Manufacturers Mergers & Acquisitions, Expansion Plans
4 BREAKDOWN DATA BY TYPE (2015-2026)
4.1 Global GABA (CAS 56-12-2) Market Size by Type (2015-2020)
4.1.1 Global GABA (CAS 56-12-2) Sales by Type (2015-2020)
4.1.2 Global GABA (CAS 56-12-2) Revenue by Type (2015-2020)
4.1.3 GABA (CAS 56-12-2) Average Selling Price (ASP) by Type (2015-2026)
4.2 Global GABA (CAS 56-12-2) Market Size Forecast by Type (2021-2026)
4.2.1 Global GABA (CAS 56-12-2) Sales Forecast by Type (2021-2026)
4.2.2 Global GABA (CAS 56-12-2) Revenue Forecast by Type (2021-2026)
4.2.3 GABA (CAS 56-12-2) Average Selling Price (ASP) Forecast by Type (2021-2026)
4.3 Global GABA (CAS 56-12-2) Market Share by Price Tier (2015-2020): Low-End, Mid-Range and High-End
5 BREAKDOWN DATA BY APPLICATION (2015-2026)
5.1 Global GABA (CAS 56-12-2) Market Size by Application (2015-2020)
5.1.1 Global GABA (CAS 56-12-2) Sales by Application (2015-2020)
5.1.2 Global GABA (CAS 56-12-2) Revenue by Application (2015-2020)
5.1.3 GABA (CAS 56-12-2) Price by Application (2015-2020)
5.2 GABA (CAS 56-12-2) Market Size Forecast by Application (2021-2026)
5.2.1 Global GABA (CAS 56-12-2) Sales Forecast by Application (2021-2026)
5.2.2 Global GABA (CAS 56-12-2) Revenue Forecast by Application (2021-2026)
5.2.3 Global GABA (CAS 56-12-2) Price Forecast by Application (2021-2026)
6 NORTH AMERICA
6.1 North America GABA (CAS 56-12-2) by Country
6.1.1 North America GABA (CAS 56-12-2) Sales by Country
6.1.2 North America GABA (CAS 56-12-2) Revenue by Country
6.1.3 U.S.
6.1.4 Canada
6.2 North America GABA (CAS 56-12-2) Market Facts & Figures by Type
6.3 North America GABA (CAS 56-12-2) Market Facts & Figures by Application
7 EUROPE
7.1 Europe GABA (CAS 56-12-2) by Country
7.1.1 Europe GABA (CAS 56-12-2) Sales by Country
7.1.2 Europe GABA (CAS 56-12-2) Revenue by Country
7.1.3 Germany
7.1.4 France
7.1.5 U.K.
7.1.6 Italy
7.1.7 Russia
7.2 Europe GABA (CAS 56-12-2) Market Facts & Figures by Type
7.3 Europe GABA (CAS 56-12-2) Market Facts & Figures by Application
8 ASIA PACIFIC
8.1 Asia Pacific GABA (CAS 56-12-2) by Region
8.1.1 Asia Pacific GABA (CAS 56-12-2) Sales by Region
8.1.2 Asia Pacific GABA (CAS 56-12-2) Revenue by Region
8.1.3 China
8.1.4 Japan
8.1.5 South Korea
8.1.6 India
8.1.7 Australia
8.1.8 Taiwan
8.1.9 Indonesia
8.1.10 Thailand
8.1.11 Malaysia
8.1.12 Philippines
8.1.13 Vietnam
8.2 Asia Pacific GABA (CAS 56-12-2) Market Facts & Figures by Type
8.3 Asia Pacific GABA (CAS 56-12-2) Market Facts & Figures by Application
9 LATIN AMERICA
9.1 Latin America GABA (CAS 56-12-2) by Country
9.1.1 Latin America GABA (CAS 56-12-2) Sales by Country
9.1.2 Latin America GABA (CAS 56-12-2) Revenue by Country
9.1.3 Mexico
9.1.4 Brazil
9.1.5 Argentina
9.2 Central & South America GABA (CAS 56-12-2) Market Facts & Figures by Type
9.3 Central & South America GABA (CAS 56-12-2) Market Facts & Figures by Application
10 MIDDLE EAST AND AFRICA
10.1 Middle East and Africa GABA (CAS 56-12-2) by Country
10.1.1 Middle East and Africa GABA (CAS 56-12-2) Sales by Country
10.1.2 Middle East and Africa GABA (CAS 56-12-2) Revenue by Country
10.1.3 Turkey
10.1.4 Saudi Arabia
10.1.5 UAE
10.2 Middle East and Africa GABA (CAS 56-12-2) Market Facts & Figures by Type
10.3 Middle East and Africa GABA (CAS 56-12-2) Market Facts & Figures by Application
11 COMPANY PROFILES
11.1 Pharma Foods International
11.1.1 Pharma Foods International Corporation Information
11.1.2 Pharma Foods International Description, Business Overview and Total Revenue
11.1.3 Pharma Foods International Sales, Revenue and Gross Margin (2015-2020)
11.1.4 Pharma Foods International GABA (CAS 56-12-2) Products Offered
11.1.5 Pharma Foods International Recent Development
11.2 Sekisui Chemical
11.2.1 Sekisui Chemical Corporation Information
11.2.2 Sekisui Chemical Description, Business Overview and Total Revenue
11.2.3 Sekisui Chemical Sales, Revenue and Gross Margin (2015-2020)
11.2.4 Sekisui Chemical GABA (CAS 56-12-2) Products Offered
11.2.5 Sekisui Chemical Recent Development
11.3 Zhejiang YiWan Biolabs
11.3.1 Zhejiang YiWan Biolabs Corporation Information
11.3.2 Zhejiang YiWan Biolabs Description, Business Overview and Total Revenue
11.3.3 Zhejiang YiWan Biolabs Sales, Revenue and Gross Margin (2015-2020)
11.3.4 Zhejiang YiWan Biolabs GABA (CAS 56-12-2) Products Offered
11.3.5 Zhejiang YiWan Biolabs Recent Development
11.4 Shanghai Richen
11.4.1 Shanghai Richen Corporation Information
11.4.2 Shanghai Richen Description, Business Overview and Total Revenue
11.4.3 Shanghai Richen Sales, Revenue and Gross Margin (2015-2020)
11.4.4 Shanghai Richen GABA (CAS 56-12-2) Products Offered
11.4.5 Shanghai Richen Recent Development
11.5 Guangdong Luckerkong Biotech
11.5.1 Guangdong Luckerkong Biotech Corporation Information
11.5.2 Guangdong Luckerkong Biotech Description, Business Overview and Total Revenue
11.5.3 Guangdong Luckerkong Biotech Sales, Revenue and Gross Margin (2015-2020)
11.5.4 Guangdong Luckerkong Biotech GABA (CAS 56-12-2) Products Offered
11.5.5 Guangdong Luckerkong Biotech Recent Development
11.6 Tianjin Shijitianlong Biotech
11.6.1 Tianjin Shijitianlong Biotech Corporation Information
11.6.2 Tianjin Shijitianlong Biotech Description, Business Overview and Total Revenue
11.6.3 Tianjin Shijitianlong Biotech Sales, Revenue and Gross Margin (2015-2020)
11.6.4 Tianjin Shijitianlong Biotech GABA (CAS 56-12-2) Products Offered
11.6.5 Tianjin Shijitianlong Biotech Recent Development
11.7 Ningxiang Jiayuan Biology Technology
11.7.1 Ningxiang Jiayuan Biology Technology Corporation Information
11.7.2 Ningxiang Jiayuan Biology Technology Description, Business Overview and Total Revenue
11.7.3 Ningxiang Jiayuan Biology Technology Sales, Revenue and Gross Margin (2015-2020)
11.7.4 Ningxiang Jiayuan Biology Technology GABA (CAS 56-12-2) Products Offered
11.7.5 Ningxiang Jiayuan Biology Technology Recent Development
11.8 Zhejiang Tianrui Chemical
11.8.1 Zhejiang Tianrui Chemical Corporation Information
11.8.2 Zhejiang Tianrui Chemical Description, Business Overview and Total Revenue
11.8.3 Zhejiang Tianrui Chemical Sales, Revenue and Gross Margin (2015-2020)
11.8.4 Zhejiang Tianrui Chemical GABA (CAS 56-12-2) Products Offered
11.8.5 Zhejiang Tianrui Chemical Recent Development
11.9 Taizhou Xinyou Pharmaceutical & Chemical
11.9.1 Taizhou Xinyou Pharmaceutical & Chemical Corporation Information
11.9.2 Taizhou Xinyou Pharmaceutical & Chemical Description, Business Overview and Total Revenue
11.9.3 Taizhou Xinyou Pharmaceutical & Chemical Sales, Revenue and Gross Margin (2015-2020)
11.9.4 Taizhou Xinyou Pharmaceutical & Chemical GABA (CAS 56-12-2) Products Offered
11.9.5 Taizhou Xinyou Pharmaceutical & Chemical Recent Development
11.1 Pharma Foods International
11.1.1 Pharma Foods International Corporation Information
11.1.2 Pharma Foods International Description, Business Overview and Total Revenue
11.1.3 Pharma Foods International Sales, Revenue and Gross Margin (2015-2020)
11.1.4 Pharma Foods International GABA (CAS 56-12-2) Products Offered
11.1.5 Pharma Foods International Recent Development
12 FUTURE FORECAST BY REGIONS (COUNTRIES) (2021-2026)
12.1 GABA (CAS 56-12-2) Market Estimates and Projections by Region
12.1.1 Global GABA (CAS 56-12-2) Sales Forecast by Regions 2021-2026
12.1.2 Global GABA (CAS 56-12-2) Revenue Forecast by Regions 2021-2026
12.2 North America GABA (CAS 56-12-2) Market Size Forecast (2021-2026)
12.2.1 North America: GABA (CAS 56-12-2) Sales Forecast (2021-2026)
12.2.2 North America: GABA (CAS 56-12-2) Revenue Forecast (2021-2026)
12.2.3 North America: GABA (CAS 56-12-2) Market Size Forecast by Country (2021-2026)
12.3 Europe GABA (CAS 56-12-2) Market Size Forecast (2021-2026)
12.3.1 Europe: GABA (CAS 56-12-2) Sales Forecast (2021-2026)
12.3.2 Europe: GABA (CAS 56-12-2) Revenue Forecast (2021-2026)
12.3.3 Europe: GABA (CAS 56-12-2) Market Size Forecast by Country (2021-2026)
12.4 Asia Pacific GABA (CAS 56-12-2) Market Size Forecast (2021-2026)
12.4.1 Asia Pacific: GABA (CAS 56-12-2) Sales Forecast (2021-2026)
12.4.2 Asia Pacific: GABA (CAS 56-12-2) Revenue Forecast (2021-2026)
12.4.3 Asia Pacific: GABA (CAS 56-12-2) Market Size Forecast by Region (2021-2026)
12.5 Latin America GABA (CAS 56-12-2) Market Size Forecast (2021-2026)
12.5.1 Latin America: GABA (CAS 56-12-2) Sales Forecast (2021-2026)
12.5.2 Latin America: GABA (CAS 56-12-2) Revenue Forecast (2021-2026)
12.5.3 Latin America: GABA (CAS 56-12-2) Market Size Forecast by Country (2021-2026)
12.6 Middle East and Africa GABA (CAS 56-12-2) Market Size Forecast (2021-2026)
12.6.1 Middle East and Africa: GABA (CAS 56-12-2) Sales Forecast (2021-2026)
12.6.2 Middle East and Africa: GABA (CAS 56-12-2) Revenue Forecast (2021-2026)
12.6.3 Middle East and Africa: GABA (CAS 56-12-2) Market Size Forecast by Country (2021-2026)
13 MARKET OPPORTUNITIES, CHALLENGES, RISKS AND INFLUENCES FACTORS ANALYSIS
13.1 Market Opportunities and Drivers
13.2 Market Challenges
13.3 Market Risks/Restraints
13.4 Porter’s Five Forces Analysis
13.5 Primary Interviews with Key GABA (CAS 56-12-2) Players (Opinion Leaders)
14 VALUE CHAIN AND SALES CHANNELS ANALYSIS
14.1 Value Chain Analysis
14.2 GABA (CAS 56-12-2) Customers
14.3 Sales Channels Analysis
14.3.1 Sales Channels
14.3.2 Distributors
15 RESEARCH FINDINGS AND CONCLUSION
16 APPENDIX
16.1 Research Methodology
16.1.1 Methodology/Research Approach
16.1.2 Data Source
16.2 Author Details
LIST OF TABLES
Table 1. GABA (CAS 56-12-2) Market Segments
Table 2. Ranking of Global Top GABA (CAS 56-12-2) Manufacturers by Revenue (US$ Million) in 2019
Table 3. Global GABA (CAS 56-12-2) Market Size Growth Rate by Type 2020-2026 (K MT) & (US$ Million)
Table 4. Major Manufacturers of Chemical Synthesis
Table 5. Major Manufacturers of Biological Fermentation
Table 6. COVID-19 Impact Global Market: (Four GABA (CAS 56-12-2) Market Size Forecast Scenarios)
Table 7. Opportunities and Trends for GABA (CAS 56-12-2) Players in the COVID-19 Landscape
Table 8. Present Opportunities in China & Elsewhere Due to the Coronavirus Crisis
Table 9. Key Regions/Countries Measures against Covid-19 Impact
Table 10. Proposal for GABA (CAS 56-12-2) Players to Combat Covid-19 Impact
Table 11. Global GABA (CAS 56-12-2) Market Size Growth Rate by Application 2020-2026 (K MT)
Table 12. Global GABA (CAS 56-12-2) Market Size by Region (K MT) & (US$ Million): 2020 VS 2026
Table 13. Global GABA (CAS 56-12-2) Sales by Regions 2015-2020 (K MT)
Table 14. Global GABA (CAS 56-12-2) Sales Market Share by Regions (2015-2020)
Table 15. Global GABA (CAS 56-12-2) Revenue by Regions 2015-2020 (US$ Million)
Table 16. Global GABA (CAS 56-12-2) Sales by Manufacturers (2015-2020) (K MT)
Table 17. Global GABA (CAS 56-12-2) Sales Share by Manufacturers (2015-2020)
Table 18. Global GABA (CAS 56-12-2) Manufacturers Market Concentration Ratio (CR5 and HHI) (2015-2020)
Table 19. Global GABA (CAS 56-12-2) by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in GABA (CAS 56-12-2) as of 2019)
Table 20. GABA (CAS 56-12-2) Revenue by Manufacturers (2015-2020) (US$ Million)
Table 21. GABA (CAS 56-12-2) Revenue Share by Manufacturers (2015-2020)
Table 22. Key Manufacturers GABA (CAS 56-12-2) Price (2015-2020) (USD/MT)
Table 23. GABA (CAS 56-12-2) Manufacturers Manufacturing Base Distribution and Headquarters
Table 24. Manufacturers GABA (CAS 56-12-2) Product Type
Table 25. Date of International Manufacturers Enter into GABA (CAS 56-12-2) Market
Table 26. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 27. Global GABA (CAS 56-12-2) Sales by Type (2015-2020) (K MT)
Table 28. Global GABA (CAS 56-12-2) Sales Share by Type (2015-2020)
Table 29. Global GABA (CAS 56-12-2) Revenue by Type (2015-2020) (US$ Million)
Table 30. Global GABA (CAS 56-12-2) Revenue Share by Type (2015-2020)
Table 31. GABA (CAS 56-12-2) Average Selling Price (ASP) by Type 2015-2020 (USD/MT)
Table 32. Global GABA (CAS 56-12-2) Sales by Application (2015-2020) (K MT)
Table 33. Global GABA (CAS 56-12-2) Sales Share by Application (2015-2020)
Table 34. North America GABA (CAS 56-12-2) Sales by Country (2015-2020) (K MT)
Table 35. North America GABA (CAS 56-12-2) Sales Market Share by Country (2015-2020)
Table 36. North America GABA (CAS 56-12-2) Revenue by Country (2015-2020) (US$ Million)
Table 37. North America GABA (CAS 56-12-2) Revenue Market Share by Country (2015-2020)
Table 38. North America GABA (CAS 56-12-2) Sales by Type (2015-2020) (K MT)
Table 39. North America GABA (CAS 56-12-2) Sales Market Share by Type (2015-2020)
Table 40. North America GABA (CAS 56-12-2) Sales by Application (2015-2020) (K MT)
Table 41. North America GABA (CAS 56-12-2) Sales Market Share by Application (2015-2020)
Table 42. Europe GABA (CAS 56-12-2) Sales by Country (2015-2020) (K MT)
Table 43. Europe GABA (CAS 56-12-2) Sales Market Share by Country (2015-2020)
Table 44. Europe GABA (CAS 56-12-2) Revenue by Country (2015-2020) (US$ Million)
Table 45. Europe GABA (CAS 56-12-2) Revenue Market Share by Country (2015-2020)
Table 46. Europe GABA (CAS 56-12-2) Sales by Type (2015-2020) (K MT)
Table 47. Europe GABA (CAS 56-12-2) Sales Market Share by Type (2015-2020)
Table 48. Europe GABA (CAS 56-12-2) Sales by Application (2015-2020) (K MT)
Table 49. Europe GABA (CAS 56-12-2) Sales Market Share by Application (2015-2020)
Table 50. Asia Pacific GABA (CAS 56-12-2) Sales by Region (2015-2020) (K MT)
Table 51. Asia Pacific GABA (CAS 56-12-2) Sales Market Share by Region (2015-2020)
Table 52. Asia Pacific GABA (CAS 56-12-2) Revenue by Region (2015-2020) (US$ Million)
Table 53. Asia Pacific GABA (CAS 56-12-2) Revenue Market Share by Region (2015-2020)
Table 54. Asia Pacific GABA (CAS 56-12-2) Sales by Type (2015-2020) (K MT)
Table 55. Asia Pacific GABA (CAS 56-12-2) Sales Market Share by Type (2015-2020)
Table 56. Asia Pacific GABA (CAS 56-12-2) Sales by Application (2015-2020) (K MT)
Table 57. Asia Pacific GABA (CAS 56-12-2) Sales Market Share by Application (2015-2020)
Table 58. Latin America GABA (CAS 56-12-2) Sales by Country (2015-2020) (K MT)
Table 59. Latin America GABA (CAS 56-12-2) Sales Market Share by Country (2015-2020)
Table 60. Latin Americaa GABA (CAS 56-12-2) Revenue by Country (2015-2020) (US$ Million)
Table 61. Latin America GABA (CAS 56-12-2) Revenue Market Share by Country (2015-2020)
Table 62. Latin America GABA (CAS 56-12-2) Sales by Type (2015-2020) (K MT)
Table 63. Latin America GABA (CAS 56-12-2) Sales Market Share by Type (2015-2020)
Table 64. Latin America GABA (CAS 56-12-2) Sales by Application (2015-2020) (K MT)
Table 65. Latin America GABA (CAS 56-12-2) Sales Market Share by Application (2015-2020)
Table 66. Middle East and Africa GABA (CAS 56-12-2) Sales by Country (2015-2020) (K MT)
Table 67. Middle East and Africa GABA (CAS 56-12-2) Sales Market Share by Country (2015-2020)
Table 68. Middle East and Africa GABA (CAS 56-12-2) Revenue by Country (2015-2020) (US$ Million)
Table 69. Middle East and Africa GABA (CAS 56-12-2) Revenue Market Share by Country (2015-2020)
Table 70. Middle East and Africa GABA (CAS 56-12-2) Sales by Type (2015-2020) (K MT)
Table 71. Middle East and Africa GABA (CAS 56-12-2) Sales Market Share by Type (2015-2020)
Table 72. Middle East and Africa GABA (CAS 56-12-2) Sales by Application (2015-2020) (K MT)
Table 73. Middle East and Africa GABA (CAS 56-12-2) Sales Market Share by Application (2015-2020)
Table 74. Pharma Foods International Corporation Information
Table 75. Pharma Foods International Description and Major Businesses
Table 76. Pharma Foods International GABA (CAS 56-12-2) Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)
Table 77. Pharma Foods International Product
Table 78. Pharma Foods International Recent Development
Table 79. Sekisui Chemical Corporation Information
Table 80. Sekisui Chemical Description and Major Businesses
Table 81. Sekisui Chemical GABA (CAS 56-12-2) Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)
Table 82. Sekisui Chemical Product
Table 83. Sekisui Chemical Recent Development
Table 84. Zhejiang YiWan Biolabs Corporation Information
Table 85. Zhejiang YiWan Biolabs Description and Major Businesses
Table 86. Zhejiang YiWan Biolabs GABA (CAS 56-12-2) Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)
Table 87. Zhejiang YiWan Biolabs Product
Table 88. Zhejiang YiWan Biolabs Recent Development
Table 89. Shanghai Richen Corporation Information
Table 90. Shanghai Richen Description and Major Businesses
Table 91. Shanghai Richen GABA (CAS 56-12-2) Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)
Table 92. Shanghai Richen Product
Table 93. Shanghai Richen Recent Development
Table 94. Guangdong Luckerkong Biotech Corporation Information
Table 95. Guangdong Luckerkong Biotech Description and Major Businesses
Table 96. Guangdong Luckerkong Biotech GABA (CAS 56-12-2) Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)
Table 97. Guangdong Luckerkong Biotech Product
Table 98. Guangdong Luckerkong Biotech Recent Development
Table 99. Tianjin Shijitianlong Biotech Corporation Information
Table 100. Tianjin Shijitianlong Biotech Description and Major Businesses
Table 101. Tianjin Shijitianlong Biotech GABA (CAS 56-12-2) Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)
Table 102. Tianjin Shijitianlong Biotech Product
Table 103. Tianjin Shijitianlong Biotech Recent Development
Table 104. Ningxiang Jiayuan Biology Technology Corporation Information
Table 105. Ningxiang Jiayuan Biology Technology Description and Major Businesses
Table 106. Ningxiang Jiayuan Biology Technology GABA (CAS 56-12-2) Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)
Table 107. Ningxiang Jiayuan Biology Technology Product
Table 108. Ningxiang Jiayuan Biology Technology Recent Development
Table 109. Zhejiang Tianrui Chemical Corporation Information
Table 110. Zhejiang Tianrui Chemical Description and Major Businesses
Table 111. Zhejiang Tianrui Chemical GABA (CAS 56-12-2) Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)
Table 112. Zhejiang Tianrui Chemical Product
Table 113. Zhejiang Tianrui Chemical Recent Development
Table 114. Taizhou Xinyou Pharmaceutical & Chemical Corporation Information
Table 115. Taizhou Xinyou Pharmaceutical & Chemical Description and Major Businesses
Table 116. Taizhou Xinyou Pharmaceutical & Chemical GABA (CAS 56-12-2) Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)
Table 117. Taizhou Xinyou Pharmaceutical & Chemical Product
Table 118. Taizhou Xinyou Pharmaceutical & Chemical Recent Development
Table 119. Global GABA (CAS 56-12-2) Sales Forecast by Regions (2021-2026) (K MT)
Table 120. Global GABA (CAS 56-12-2) Sales Market Share Forecast by Regions (2021-2026)
Table 121. Global GABA (CAS 56-12-2) Revenue Forecast by Regions (2021-2026) (US$ Million)
Table 122. Global GABA (CAS 56-12-2) Revenue Market Share Forecast by Regions (2021-2026)
Table 123. North America: GABA (CAS 56-12-2) Sales Forecast by Country (2021-2026) (K MT)
Table 124. North America: GABA (CAS 56-12-2) Revenue Forecast by Country (2021-2026) (US$ Million)
Table 125. Europe: GABA (CAS 56-12-2) Sales Forecast by Country (2021-2026) (K MT)
Table 126. Europe: GABA (CAS 56-12-2) Revenue Forecast by Country (2021-2026) (US$ Million)
Table 127. Asia Pacific: GABA (CAS 56-12-2) Sales Forecast by Region (2021-2026) (K MT)
Table 128. Asia Pacific: GABA (CAS 56-12-2) Revenue Forecast by Region (2021-2026) (US$ Million)
Table 129. Latin America: GABA (CAS 56-12-2) Sales Forecast by Country (2021-2026) (K MT)
Table 130. Latin America: GABA (CAS 56-12-2) Revenue Forecast by Country (2021-2026) (US$ Million)
Table 131. Middle East and Africa: GABA (CAS 56-12-2) Sales Forecast by Country (2021-2026) (K MT)
Table 132. Middle East and Africa: GABA (CAS 56-12-2) Revenue Forecast by Country (2021-2026) (US$ Million)
Table 133. Key Opportunities and Drivers: Impact Analysis (2021-2026)
Table 134. Key Challenges
Table 135. Market Risks
Table 136. Main Points Interviewed from Key GABA (CAS 56-12-2) Players
Table 137. GABA (CAS 56-12-2) Customers List
Table 138. GABA (CAS 56-12-2) Distributors List
Table 139. Research Programs/Design for This Report
Table 140. Key Data Information from Secondary Sources
Table 141. Key Data Information from Primary Sources
Table 1. GABA (CAS 56-12-2) Market Segments
Table 2. Ranking of Global Top GABA (CAS 56-12-2) Manufacturers by Revenue (US$ Million) in 2019
Table 3. Global GABA (CAS 56-12-2) Market Size Growth Rate by Type 2020-2026 (K MT) & (US$ Million)
Table 4. Major Manufacturers of Chemical Synthesis
Table 5. Major Manufacturers of Biological Fermentation
Table 6. COVID-19 Impact Global Market: (Four GABA (CAS 56-12-2) Market Size Forecast Scenarios)
Table 7. Opportunities and Trends for GABA (CAS 56-12-2) Players in the COVID-19 Landscape
Table 8. Present Opportunities in China & Elsewhere Due to the Coronavirus Crisis
Table 9. Key Regions/Countries Measures against Covid-19 Impact
Table 10. Proposal for GABA (CAS 56-12-2) Players to Combat Covid-19 Impact
Table 11. Global GABA (CAS 56-12-2) Market Size Growth Rate by Application 2020-2026 (K MT)
Table 12. Global GABA (CAS 56-12-2) Market Size by Region (K MT) & (US$ Million): 2020 VS 2026
Table 13. Global GABA (CAS 56-12-2) Sales by Regions 2015-2020 (K MT)
Table 14. Global GABA (CAS 56-12-2) Sales Market Share by Regions (2015-2020)
Table 15. Global GABA (CAS 56-12-2) Revenue by Regions 2015-2020 (US$ Million)
Table 16. Global GABA (CAS 56-12-2) Sales by Manufacturers (2015-2020) (K MT)
Table 17. Global GABA (CAS 56-12-2) Sales Share by Manufacturers (2015-2020)
Table 18. Global GABA (CAS 56-12-2) Manufacturers Market Concentration Ratio (CR5 and HHI) (2015-2020)
Table 19. Global GABA (CAS 56-12-2) by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in GABA (CAS 56-12-2) as of 2019)
Table 20. GABA (CAS 56-12-2) Revenue by Manufacturers (2015-2020) (US$ Million)
Table 21. GABA (CAS 56-12-2) Revenue Share by Manufacturers (2015-2020)
Table 22. Key Manufacturers GABA (CAS 56-12-2) Price (2015-2020) (USD/MT)
Table 23. GABA (CAS 56-12-2) Manufacturers Manufacturing Base Distribution and Headquarters
Table 24. Manufacturers GABA (CAS 56-12-2) Product Type
Table 25. Date of International Manufacturers Enter into GABA (CAS 56-12-2) Market
Table 26. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 27. Global GABA (CAS 56-12-2) Sales by Type (2015-2020) (K MT)
Table 28. Global GABA (CAS 56-12-2) Sales Share by Type (2015-2020)
Table 29. Global GABA (CAS 56-12-2) Revenue by Type (2015-2020) (US$ Million)
Table 30. Global GABA (CAS 56-12-2) Revenue Share by Type (2015-2020)
Table 31. GABA (CAS 56-12-2) Average Selling Price (ASP) by Type 2015-2020 (USD/MT)
Table 32. Global GABA (CAS 56-12-2) Sales by Application (2015-2020) (K MT)
Table 33. Global GABA (CAS 56-12-2) Sales Share by Application (2015-2020)
Table 34. North America GABA (CAS 56-12-2) Sales by Country (2015-2020) (K MT)
Table 35. North America GABA (CAS 56-12-2) Sales Market Share by Country (2015-2020)
Table 36. North America GABA (CAS 56-12-2) Revenue by Country (2015-2020) (US$ Million)
Table 37. North America GABA (CAS 56-12-2) Revenue Market Share by Country (2015-2020)
Table 38. North America GABA (CAS 56-12-2) Sales by Type (2015-2020) (K MT)
Table 39. North America GABA (CAS 56-12-2) Sales Market Share by Type (2015-2020)
Table 40. North America GABA (CAS 56-12-2) Sales by Application (2015-2020) (K MT)
Table 41. North America GABA (CAS 56-12-2) Sales Market Share by Application (2015-2020)
Table 42. Europe GABA (CAS 56-12-2) Sales by Country (2015-2020) (K MT)
Table 43. Europe GABA (CAS 56-12-2) Sales Market Share by Country (2015-2020)
Table 44. Europe GABA (CAS 56-12-2) Revenue by Country (2015-2020) (US$ Million)
Table 45. Europe GABA (CAS 56-12-2) Revenue Market Share by Country (2015-2020)
Table 46. Europe GABA (CAS 56-12-2) Sales by Type (2015-2020) (K MT)
Table 47. Europe GABA (CAS 56-12-2) Sales Market Share by Type (2015-2020)
Table 48. Europe GABA (CAS 56-12-2) Sales by Application (2015-2020) (K MT)
Table 49. Europe GABA (CAS 56-12-2) Sales Market Share by Application (2015-2020)
Table 50. Asia Pacific GABA (CAS 56-12-2) Sales by Region (2015-2020) (K MT)
Table 51. Asia Pacific GABA (CAS 56-12-2) Sales Market Share by Region (2015-2020)
Table 52. Asia Pacific GABA (CAS 56-12-2) Revenue by Region (2015-2020) (US$ Million)
Table 53. Asia Pacific GABA (CAS 56-12-2) Revenue Market Share by Region (2015-2020)
Table 54. Asia Pacific GABA (CAS 56-12-2) Sales by Type (2015-2020) (K MT)
Table 55. Asia Pacific GABA (CAS 56-12-2) Sales Market Share by Type (2015-2020)
Table 56. Asia Pacific GABA (CAS 56-12-2) Sales by Application (2015-2020) (K MT)
Table 57. Asia Pacific GABA (CAS 56-12-2) Sales Market Share by Application (2015-2020)
Table 58. Latin America GABA (CAS 56-12-2) Sales by Country (2015-2020) (K MT)
Table 59. Latin America GABA (CAS 56-12-2) Sales Market Share by Country (2015-2020)
Table 60. Latin Americaa GABA (CAS 56-12-2) Revenue by Country (2015-2020) (US$ Million)
Table 61. Latin America GABA (CAS 56-12-2) Revenue Market Share by Country (2015-2020)
Table 62. Latin America GABA (CAS 56-12-2) Sales by Type (2015-2020) (K MT)
Table 63. Latin America GABA (CAS 56-12-2) Sales Market Share by Type (2015-2020)
Table 64. Latin America GABA (CAS 56-12-2) Sales by Application (2015-2020) (K MT)
Table 65. Latin America GABA (CAS 56-12-2) Sales Market Share by Application (2015-2020)
Table 66. Middle East and Africa GABA (CAS 56-12-2) Sales by Country (2015-2020) (K MT)
Table 67. Middle East and Africa GABA (CAS 56-12-2) Sales Market Share by Country (2015-2020)
Table 68. Middle East and Africa GABA (CAS 56-12-2) Revenue by Country (2015-2020) (US$ Million)
Table 69. Middle East and Africa GABA (CAS 56-12-2) Revenue Market Share by Country (2015-2020)
Table 70. Middle East and Africa GABA (CAS 56-12-2) Sales by Type (2015-2020) (K MT)
Table 71. Middle East and Africa GABA (CAS 56-12-2) Sales Market Share by Type (2015-2020)
Table 72. Middle East and Africa GABA (CAS 56-12-2) Sales by Application (2015-2020) (K MT)
Table 73. Middle East and Africa GABA (CAS 56-12-2) Sales Market Share by Application (2015-2020)
Table 74. Pharma Foods International Corporation Information
Table 75. Pharma Foods International Description and Major Businesses
Table 76. Pharma Foods International GABA (CAS 56-12-2) Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)
Table 77. Pharma Foods International Product
Table 78. Pharma Foods International Recent Development
Table 79. Sekisui Chemical Corporation Information
Table 80. Sekisui Chemical Description and Major Businesses
Table 81. Sekisui Chemical GABA (CAS 56-12-2) Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)
Table 82. Sekisui Chemical Product
Table 83. Sekisui Chemical Recent Development
Table 84. Zhejiang YiWan Biolabs Corporation Information
Table 85. Zhejiang YiWan Biolabs Description and Major Businesses
Table 86. Zhejiang YiWan Biolabs GABA (CAS 56-12-2) Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)
Table 87. Zhejiang YiWan Biolabs Product
Table 88. Zhejiang YiWan Biolabs Recent Development
Table 89. Shanghai Richen Corporation Information
Table 90. Shanghai Richen Description and Major Businesses
Table 91. Shanghai Richen GABA (CAS 56-12-2) Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)
Table 92. Shanghai Richen Product
Table 93. Shanghai Richen Recent Development
Table 94. Guangdong Luckerkong Biotech Corporation Information
Table 95. Guangdong Luckerkong Biotech Description and Major Businesses
Table 96. Guangdong Luckerkong Biotech GABA (CAS 56-12-2) Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)
Table 97. Guangdong Luckerkong Biotech Product
Table 98. Guangdong Luckerkong Biotech Recent Development
Table 99. Tianjin Shijitianlong Biotech Corporation Information
Table 100. Tianjin Shijitianlong Biotech Description and Major Businesses
Table 101. Tianjin Shijitianlong Biotech GABA (CAS 56-12-2) Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)
Table 102. Tianjin Shijitianlong Biotech Product
Table 103. Tianjin Shijitianlong Biotech Recent Development
Table 104. Ningxiang Jiayuan Biology Technology Corporation Information
Table 105. Ningxiang Jiayuan Biology Technology Description and Major Businesses
Table 106. Ningxiang Jiayuan Biology Technology GABA (CAS 56-12-2) Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)
Table 107. Ningxiang Jiayuan Biology Technology Product
Table 108. Ningxiang Jiayuan Biology Technology Recent Development
Table 109. Zhejiang Tianrui Chemical Corporation Information
Table 110. Zhejiang Tianrui Chemical Description and Major Businesses
Table 111. Zhejiang Tianrui Chemical GABA (CAS 56-12-2) Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)
Table 112. Zhejiang Tianrui Chemical Product
Table 113. Zhejiang Tianrui Chemical Recent Development
Table 114. Taizhou Xinyou Pharmaceutical & Chemical Corporation Information
Table 115. Taizhou Xinyou Pharmaceutical & Chemical Description and Major Businesses
Table 116. Taizhou Xinyou Pharmaceutical & Chemical GABA (CAS 56-12-2) Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)
Table 117. Taizhou Xinyou Pharmaceutical & Chemical Product
Table 118. Taizhou Xinyou Pharmaceutical & Chemical Recent Development
Table 119. Global GABA (CAS 56-12-2) Sales Forecast by Regions (2021-2026) (K MT)
Table 120. Global GABA (CAS 56-12-2) Sales Market Share Forecast by Regions (2021-2026)
Table 121. Global GABA (CAS 56-12-2) Revenue Forecast by Regions (2021-2026) (US$ Million)
Table 122. Global GABA (CAS 56-12-2) Revenue Market Share Forecast by Regions (2021-2026)
Table 123. North America: GABA (CAS 56-12-2) Sales Forecast by Country (2021-2026) (K MT)
Table 124. North America: GABA (CAS 56-12-2) Revenue Forecast by Country (2021-2026) (US$ Million)
Table 125. Europe: GABA (CAS 56-12-2) Sales Forecast by Country (2021-2026) (K MT)
Table 126. Europe: GABA (CAS 56-12-2) Revenue Forecast by Country (2021-2026) (US$ Million)
Table 127. Asia Pacific: GABA (CAS 56-12-2) Sales Forecast by Region (2021-2026) (K MT)
Table 128. Asia Pacific: GABA (CAS 56-12-2) Revenue Forecast by Region (2021-2026) (US$ Million)
Table 129. Latin America: GABA (CAS 56-12-2) Sales Forecast by Country (2021-2026) (K MT)
Table 130. Latin America: GABA (CAS 56-12-2) Revenue Forecast by Country (2021-2026) (US$ Million)
Table 131. Middle East and Africa: GABA (CAS 56-12-2) Sales Forecast by Country (2021-2026) (K MT)
Table 132. Middle East and Africa: GABA (CAS 56-12-2) Revenue Forecast by Country (2021-2026) (US$ Million)
Table 133. Key Opportunities and Drivers: Impact Analysis (2021-2026)
Table 134. Key Challenges
Table 135. Market Risks
Table 136. Main Points Interviewed from Key GABA (CAS 56-12-2) Players
Table 137. GABA (CAS 56-12-2) Customers List
Table 138. GABA (CAS 56-12-2) Distributors List
Table 139. Research Programs/Design for This Report
Table 140. Key Data Information from Secondary Sources
Table 141. Key Data Information from Primary Sources
LIST OF FIGURES
Figure 1. GABA (CAS 56-12-2) Product Picture
Figure 2. Global GABA (CAS 56-12-2) Sales Market Share by Type in 2020 & 2026
Figure 3. Chemical Synthesis Product Picture
Figure 4. Biological Fermentation Product Picture
Figure 5. Global GABA (CAS 56-12-2) Sales Market Share by Application in 2020 & 2026
Figure 6. Pharmaceuticals
Figure 7. Food & Beverage
Figure 8. Animal Feeds
Figure 9. Others
Figure 10. GABA (CAS 56-12-2) Report Years Considered
Figure 11. Global GABA (CAS 56-12-2) Market Size 2015-2026 (US$ Million)
Figure 12. Global GABA (CAS 56-12-2) Sales 2015-2026 (K MT)
Figure 13. Global GABA (CAS 56-12-2) Market Size Market Share by Region: 2020 Versus 2026
Figure 14. Global GABA (CAS 56-12-2) Sales Market Share by Region (2015-2020)
Figure 15. Global GABA (CAS 56-12-2) Sales Market Share by Region in 2019
Figure 16. Global GABA (CAS 56-12-2) Revenue Market Share by Region (2015-2020)
Figure 17. Global GABA (CAS 56-12-2) Revenue Market Share by Region in 2019
Figure 18. Global GABA (CAS 56-12-2) Sales Share by Manufacturer in 2019
Figure 19. The Top 10 and 5 Players Market Share by GABA (CAS 56-12-2) Revenue in 2019
Figure 20. GABA (CAS 56-12-2) Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2015 VS 2019
Figure 21. Global GABA (CAS 56-12-2) Sales Market Share by Type (2015-2020)
Figure 22. Global GABA (CAS 56-12-2) Sales Market Share by Type in 2019
Figure 23. Global GABA (CAS 56-12-2) Revenue Market Share by Type (2015-2020)
Figure 24. Global GABA (CAS 56-12-2) Revenue Market Share by Type in 2019
Figure 25. Global GABA (CAS 56-12-2) Market Share by Price Range (2015-2020)
Figure 26. Global GABA (CAS 56-12-2) Sales Market Share by Application (2015-2020)
Figure 27. Global GABA (CAS 56-12-2) Sales Market Share by Application in 2019
Figure 28. Global GABA (CAS 56-12-2) Revenue Market Share by Application (2015-2020)
Figure 29. Global GABA (CAS 56-12-2) Revenue Market Share by Application in 2019
Figure 30. North America GABA (CAS 56-12-2) Sales Growth Rate 2015-2020 (K MT)
Figure 31. North America GABA (CAS 56-12-2) Revenue Growth Rate 2015-2020 (US$ Million)
Figure 32. North America GABA (CAS 56-12-2) Sales Market Share by Country in 2019
Figure 33. North America GABA (CAS 56-12-2) Revenue Market Share by Country in 2019
Figure 34. U.S. GABA (CAS 56-12-2) Sales Growth Rate (2015-2020) (K MT)
Figure 35. U.S. GABA (CAS 56-12-2) Revenue Growth Rate (2015-2020) (US$ Million)
Figure 36. Canada GABA (CAS 56-12-2) Sales Growth Rate (2015-2020) (K MT)
Figure 37. Canada GABA (CAS 56-12-2) Revenue Growth Rate (2015-2020) (US$ Million)
Figure 38. North America GABA (CAS 56-12-2) Market Share by Type in 2019
Figure 39. North America GABA (CAS 56-12-2) Market Share by Application in 2019
Figure 40. Europe GABA (CAS 56-12-2) Sales Growth Rate 2015-2020 (K MT)
Figure 41. Europe GABA (CAS 56-12-2) Revenue Growth Rate 2015-2020 (US$ Million)
Figure 42. Europe GABA (CAS 56-12-2) Sales Market Share by Country in 2019
Figure 43. Europe GABA (CAS 56-12-2) Revenue Market Share by Country in 2019
Figure 44. Germany GABA (CAS 56-12-2) Sales Growth Rate (2015-2020) (K MT)
Figure 45. Germany GABA (CAS 56-12-2) Revenue Growth Rate (2015-2020) (US$ Million)
Figure 46. France GABA (CAS 56-12-2) Sales Growth Rate (2015-2020) (K MT)
Figure 47. France GABA (CAS 56-12-2) Revenue Growth Rate (2015-2020) (US$ Million)
Figure 48. U.K. GABA (CAS 56-12-2) Sales Growth Rate (2015-2020) (K MT)
Figure 49. U.K. GABA (CAS 56-12-2) Revenue Growth Rate (2015-2020) (US$ Million)
Figure 50. Italy GABA (CAS 56-12-2) Sales Growth Rate (2015-2020) (K MT)
Figure 51. Italy GABA (CAS 56-12-2) Revenue Growth Rate (2015-2020) (US$ Million)
Figure 52. Russia GABA (CAS 56-12-2) Sales Growth Rate (2015-2020) (K MT)
Figure 53. Russia GABA (CAS 56-12-2) Revenue Growth Rate (2015-2020) (US$ Million)
Figure 54. Europe GABA (CAS 56-12-2) Market Share by Type in 2019
Figure 55. Europe GABA (CAS 56-12-2) Market Share by Application in 2019
Figure 56. Asia Pacific GABA (CAS 56-12-2) Sales Growth Rate 2015-2020 (K MT)
Figure 57. Asia Pacific GABA (CAS 56-12-2) Revenue Growth Rate 2015-2020 (US$ Million)
Figure 58. Asia Pacific GABA (CAS 56-12-2) Sales Market Share by Region in 2019
Figure 59. Asia Pacific GABA (CAS 56-12-2) Revenue Market Share by Region in 2019
Figure 60. China GABA (CAS 56-12-2) Sales Growth Rate (2015-2020) (K MT)
Figure 61. China GABA (CAS 56-12-2) Revenue Growth Rate (2015-2020) (US$ Million)
Figure 62. Japan GABA (CAS 56-12-2) Sales Growth Rate (2015-2020) (K MT)
Figure 63. Japan GABA (CAS 56-12-2) Revenue Growth Rate (2015-2020) (US$ Million)
Figure 64. South Korea GABA (CAS 56-12-2) Sales Growth Rate (2015-2020) (K MT)
Figure 65. South Korea GABA (CAS 56-12-2) Revenue Growth Rate (2015-2020) (US$ Million)
Figure 66. India GABA (CAS 56-12-2) Sales Growth Rate (2015-2020) (K MT)
Figure 67. India GABA (CAS 56-12-2) Revenue Growth Rate (2015-2020) (US$ Million)
Figure 68. Australia GABA (CAS 56-12-2) Sales Growth Rate (2015-2020) (K MT)
Figure 69. Australia GABA (CAS 56-12-2) Revenue Growth Rate (2015-2020) (US$ Million)
Figure 70. Taiwan GABA (CAS 56-12-2) Sales Growth Rate (2015-2020) (K MT)
Figure 71. Taiwan GABA (CAS 56-12-2) Revenue Growth Rate (2015-2020) (US$ Million)
Figure 72. Indonesia GABA (CAS 56-12-2) Sales Growth Rate (2015-2020) (K MT)
Figure 73. Indonesia GABA (CAS 56-12-2) Revenue Growth Rate (2015-2020) (US$ Million)
Figure 74. Thailand GABA (CAS 56-12-2) Sales Growth Rate (2015-2020) (K MT)
Figure 75. Thailand GABA (CAS 56-12-2) Revenue Growth Rate (2015-2020) (US$ Million)
Figure 76. Malaysia GABA (CAS 56-12-2) Sales Growth Rate (2015-2020) (K MT)
Figure 77. Malaysia GABA (CAS 56-12-2) Revenue Growth Rate (2015-2020) (US$ Million)
Figure 78. Philippines GABA (CAS 56-12-2) Sales Growth Rate (2015-2020) (K MT)
Figure 79. Philippines GABA (CAS 56-12-2) Revenue Growth Rate (2015-2020) (US$ Million)
Figure 80. Vietnam GABA (CAS 56-12-2) Sales Growth Rate (2015-2020) (K MT)
Figure 81. Vietnam GABA (CAS 56-12-2) Revenue Growth Rate (2015-2020) (US$ Million)
Figure 82. Asia Pacific GABA (CAS 56-12-2) Market Share by Type in 2019
Figure 83. Asia Pacific GABA (CAS 56-12-2) Market Share by Application in 2019
Figure 84. Latin America GABA (CAS 56-12-2) Sales Growth Rate 2015-2020 (K MT)
Figure 85. Latin America GABA (CAS 56-12-2) Revenue Growth Rate 2015-2020 (US$ Million)
Figure 86. Latin America GABA (CAS 56-12-2) Sales Market Share by Country in 2019
Figure 87. Latin America GABA (CAS 56-12-2) Revenue Market Share by Country in 2019
Figure 88. Mexico GABA (CAS 56-12-2) Sales Growth Rate (2015-2020) (K MT)
Figure 89. Mexico GABA (CAS 56-12-2) Revenue Growth Rate (2015-2020) (US$ Million)
Figure 90. Brazil GABA (CAS 56-12-2) Sales Growth Rate (2015-2020) (K MT)
Figure 91. Brazil GABA (CAS 56-12-2) Revenue Growth Rate (2015-2020) (US$ Million)
Figure 92. Argentina GABA (CAS 56-12-2) Sales Growth Rate (2015-2020) (K MT)
Figure 93. Argentina GABA (CAS 56-12-2) Revenue Growth Rate (2015-2020) (US$ Million)
Figure 94. Latin America GABA (CAS 56-12-2) Market Share by Type in 2019
Figure 95. Latin America GABA (CAS 56-12-2) Market Share by Application in 2019
Figure 96. Middle East and Africa GABA (CAS 56-12-2) Sales Growth Rate 2015-2020 (K MT)
Figure 97. Middle East and Africa GABA (CAS 56-12-2) Revenue Growth Rate 2015-2020 (US$ Million)
Figure 98. Middle East and Africa GABA (CAS 56-12-2) Sales Market Share by Country in 2019
Figure 99. Middle East and Africa GABA (CAS 56-12-2) Revenue Market Share by Country in 2019
Figure 100. Turkey GABA (CAS 56-12-2) Sales Growth Rate (2015-2020) (K MT)
Figure 101. Turkey GABA (CAS 56-12-2) Revenue Growth Rate (2015-2020) (US$ Million)
Figure 102. Saudi Arabia GABA (CAS 56-12-2) Sales Growth Rate (2015-2020) (K MT)
Figure 103. Saudi Arabia GABA (CAS 56-12-2) Revenue Growth Rate (2015-2020) (US$ Million)
Figure 104. UAE GABA (CAS 56-12-2) Sales Growth Rate (2015-2020) (K MT)
Figure 105. UAE GABA (CAS 56-12-2) Revenue Growth Rate (2015-2020) (US$ Million)
Figure 106. Middle East and Africa GABA (CAS 56-12-2) Market Share by Type in 2019
Figure 107. Middle East and Africa GABA (CAS 56-12-2) Market Share by Application in 2019
Figure 108. Pharma Foods International Total Revenue (US$ Million): 2019 Compared with 2018
Figure 109. Sekisui Chemical Total Revenue (US$ Million): 2019 Compared with 2018
Figure 110. Zhejiang YiWan Biolabs Total Revenue (US$ Million): 2019 Compared with 2018
Figure 111. Shanghai Richen Total Revenue (US$ Million): 2019 Compared with 2018
Figure 112. Guangdong Luckerkong Biotech Total Revenue (US$ Million): 2019 Compared with 2018
Figure 113. Tianjin Shijitianlong Biotech Total Revenue (US$ Million): 2019 Compared with 2018
Figure 114. Ningxiang Jiayuan Biology Technology Total Revenue (US$ Million): 2019 Compared with 2018
Figure 115. Zhejiang Tianrui Chemical Total Revenue (US$ Million): 2019 Compared with 2018
Figure 116. Taizhou Xinyou Pharmaceutical & Chemical Total Revenue (US$ Million): 2019 Compared with 2018
Figure 117. North America GABA (CAS 56-12-2) Sales Growth Rate Forecast (2021-2026) (K MT)
Figure 118. North America GABA (CAS 56-12-2) Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 119. Europe GABA (CAS 56-12-2) Sales Growth Rate Forecast (2021-2026) (K MT)
Figure 120. Europe GABA (CAS 56-12-2) Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 121. Asia Pacific GABA (CAS 56-12-2) Sales Growth Rate Forecast (2021-2026) (K MT)
Figure 122. Asia Pacific GABA (CAS 56-12-2) Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 123. Latin America GABA (CAS 56-12-2) Sales Growth Rate Forecast (2021-2026) (K MT)
Figure 124. Latin America GABA (CAS 56-12-2) Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 125. Middle East and Africa GABA (CAS 56-12-2) Sales Growth Rate Forecast (2021-2026) (K MT)
Figure 126. Middle East and Africa GABA (CAS 56-12-2) Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 127. Porter's Five Forces Analysis
Figure 128. Channels of Distribution
Figure 129. Distributors Profiles
Figure 130. Bottom-up and Top-down Approaches for This Report
Figure 131. Data Triangulation
Figure 132. Key Executives Interviewed
Figure 1. GABA (CAS 56-12-2) Product Picture
Figure 2. Global GABA (CAS 56-12-2) Sales Market Share by Type in 2020 & 2026
Figure 3. Chemical Synthesis Product Picture
Figure 4. Biological Fermentation Product Picture
Figure 5. Global GABA (CAS 56-12-2) Sales Market Share by Application in 2020 & 2026
Figure 6. Pharmaceuticals
Figure 7. Food & Beverage
Figure 8. Animal Feeds
Figure 9. Others
Figure 10. GABA (CAS 56-12-2) Report Years Considered
Figure 11. Global GABA (CAS 56-12-2) Market Size 2015-2026 (US$ Million)
Figure 12. Global GABA (CAS 56-12-2) Sales 2015-2026 (K MT)
Figure 13. Global GABA (CAS 56-12-2) Market Size Market Share by Region: 2020 Versus 2026
Figure 14. Global GABA (CAS 56-12-2) Sales Market Share by Region (2015-2020)
Figure 15. Global GABA (CAS 56-12-2) Sales Market Share by Region in 2019
Figure 16. Global GABA (CAS 56-12-2) Revenue Market Share by Region (2015-2020)
Figure 17. Global GABA (CAS 56-12-2) Revenue Market Share by Region in 2019
Figure 18. Global GABA (CAS 56-12-2) Sales Share by Manufacturer in 2019
Figure 19. The Top 10 and 5 Players Market Share by GABA (CAS 56-12-2) Revenue in 2019
Figure 20. GABA (CAS 56-12-2) Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2015 VS 2019
Figure 21. Global GABA (CAS 56-12-2) Sales Market Share by Type (2015-2020)
Figure 22. Global GABA (CAS 56-12-2) Sales Market Share by Type in 2019
Figure 23. Global GABA (CAS 56-12-2) Revenue Market Share by Type (2015-2020)
Figure 24. Global GABA (CAS 56-12-2) Revenue Market Share by Type in 2019
Figure 25. Global GABA (CAS 56-12-2) Market Share by Price Range (2015-2020)
Figure 26. Global GABA (CAS 56-12-2) Sales Market Share by Application (2015-2020)
Figure 27. Global GABA (CAS 56-12-2) Sales Market Share by Application in 2019
Figure 28. Global GABA (CAS 56-12-2) Revenue Market Share by Application (2015-2020)
Figure 29. Global GABA (CAS 56-12-2) Revenue Market Share by Application in 2019
Figure 30. North America GABA (CAS 56-12-2) Sales Growth Rate 2015-2020 (K MT)
Figure 31. North America GABA (CAS 56-12-2) Revenue Growth Rate 2015-2020 (US$ Million)
Figure 32. North America GABA (CAS 56-12-2) Sales Market Share by Country in 2019
Figure 33. North America GABA (CAS 56-12-2) Revenue Market Share by Country in 2019
Figure 34. U.S. GABA (CAS 56-12-2) Sales Growth Rate (2015-2020) (K MT)
Figure 35. U.S. GABA (CAS 56-12-2) Revenue Growth Rate (2015-2020) (US$ Million)
Figure 36. Canada GABA (CAS 56-12-2) Sales Growth Rate (2015-2020) (K MT)
Figure 37. Canada GABA (CAS 56-12-2) Revenue Growth Rate (2015-2020) (US$ Million)
Figure 38. North America GABA (CAS 56-12-2) Market Share by Type in 2019
Figure 39. North America GABA (CAS 56-12-2) Market Share by Application in 2019
Figure 40. Europe GABA (CAS 56-12-2) Sales Growth Rate 2015-2020 (K MT)
Figure 41. Europe GABA (CAS 56-12-2) Revenue Growth Rate 2015-2020 (US$ Million)
Figure 42. Europe GABA (CAS 56-12-2) Sales Market Share by Country in 2019
Figure 43. Europe GABA (CAS 56-12-2) Revenue Market Share by Country in 2019
Figure 44. Germany GABA (CAS 56-12-2) Sales Growth Rate (2015-2020) (K MT)
Figure 45. Germany GABA (CAS 56-12-2) Revenue Growth Rate (2015-2020) (US$ Million)
Figure 46. France GABA (CAS 56-12-2) Sales Growth Rate (2015-2020) (K MT)
Figure 47. France GABA (CAS 56-12-2) Revenue Growth Rate (2015-2020) (US$ Million)
Figure 48. U.K. GABA (CAS 56-12-2) Sales Growth Rate (2015-2020) (K MT)
Figure 49. U.K. GABA (CAS 56-12-2) Revenue Growth Rate (2015-2020) (US$ Million)
Figure 50. Italy GABA (CAS 56-12-2) Sales Growth Rate (2015-2020) (K MT)
Figure 51. Italy GABA (CAS 56-12-2) Revenue Growth Rate (2015-2020) (US$ Million)
Figure 52. Russia GABA (CAS 56-12-2) Sales Growth Rate (2015-2020) (K MT)
Figure 53. Russia GABA (CAS 56-12-2) Revenue Growth Rate (2015-2020) (US$ Million)
Figure 54. Europe GABA (CAS 56-12-2) Market Share by Type in 2019
Figure 55. Europe GABA (CAS 56-12-2) Market Share by Application in 2019
Figure 56. Asia Pacific GABA (CAS 56-12-2) Sales Growth Rate 2015-2020 (K MT)
Figure 57. Asia Pacific GABA (CAS 56-12-2) Revenue Growth Rate 2015-2020 (US$ Million)
Figure 58. Asia Pacific GABA (CAS 56-12-2) Sales Market Share by Region in 2019
Figure 59. Asia Pacific GABA (CAS 56-12-2) Revenue Market Share by Region in 2019
Figure 60. China GABA (CAS 56-12-2) Sales Growth Rate (2015-2020) (K MT)
Figure 61. China GABA (CAS 56-12-2) Revenue Growth Rate (2015-2020) (US$ Million)
Figure 62. Japan GABA (CAS 56-12-2) Sales Growth Rate (2015-2020) (K MT)
Figure 63. Japan GABA (CAS 56-12-2) Revenue Growth Rate (2015-2020) (US$ Million)
Figure 64. South Korea GABA (CAS 56-12-2) Sales Growth Rate (2015-2020) (K MT)
Figure 65. South Korea GABA (CAS 56-12-2) Revenue Growth Rate (2015-2020) (US$ Million)
Figure 66. India GABA (CAS 56-12-2) Sales Growth Rate (2015-2020) (K MT)
Figure 67. India GABA (CAS 56-12-2) Revenue Growth Rate (2015-2020) (US$ Million)
Figure 68. Australia GABA (CAS 56-12-2) Sales Growth Rate (2015-2020) (K MT)
Figure 69. Australia GABA (CAS 56-12-2) Revenue Growth Rate (2015-2020) (US$ Million)
Figure 70. Taiwan GABA (CAS 56-12-2) Sales Growth Rate (2015-2020) (K MT)
Figure 71. Taiwan GABA (CAS 56-12-2) Revenue Growth Rate (2015-2020) (US$ Million)
Figure 72. Indonesia GABA (CAS 56-12-2) Sales Growth Rate (2015-2020) (K MT)
Figure 73. Indonesia GABA (CAS 56-12-2) Revenue Growth Rate (2015-2020) (US$ Million)
Figure 74. Thailand GABA (CAS 56-12-2) Sales Growth Rate (2015-2020) (K MT)
Figure 75. Thailand GABA (CAS 56-12-2) Revenue Growth Rate (2015-2020) (US$ Million)
Figure 76. Malaysia GABA (CAS 56-12-2) Sales Growth Rate (2015-2020) (K MT)
Figure 77. Malaysia GABA (CAS 56-12-2) Revenue Growth Rate (2015-2020) (US$ Million)
Figure 78. Philippines GABA (CAS 56-12-2) Sales Growth Rate (2015-2020) (K MT)
Figure 79. Philippines GABA (CAS 56-12-2) Revenue Growth Rate (2015-2020) (US$ Million)
Figure 80. Vietnam GABA (CAS 56-12-2) Sales Growth Rate (2015-2020) (K MT)
Figure 81. Vietnam GABA (CAS 56-12-2) Revenue Growth Rate (2015-2020) (US$ Million)
Figure 82. Asia Pacific GABA (CAS 56-12-2) Market Share by Type in 2019
Figure 83. Asia Pacific GABA (CAS 56-12-2) Market Share by Application in 2019
Figure 84. Latin America GABA (CAS 56-12-2) Sales Growth Rate 2015-2020 (K MT)
Figure 85. Latin America GABA (CAS 56-12-2) Revenue Growth Rate 2015-2020 (US$ Million)
Figure 86. Latin America GABA (CAS 56-12-2) Sales Market Share by Country in 2019
Figure 87. Latin America GABA (CAS 56-12-2) Revenue Market Share by Country in 2019
Figure 88. Mexico GABA (CAS 56-12-2) Sales Growth Rate (2015-2020) (K MT)
Figure 89. Mexico GABA (CAS 56-12-2) Revenue Growth Rate (2015-2020) (US$ Million)
Figure 90. Brazil GABA (CAS 56-12-2) Sales Growth Rate (2015-2020) (K MT)
Figure 91. Brazil GABA (CAS 56-12-2) Revenue Growth Rate (2015-2020) (US$ Million)
Figure 92. Argentina GABA (CAS 56-12-2) Sales Growth Rate (2015-2020) (K MT)
Figure 93. Argentina GABA (CAS 56-12-2) Revenue Growth Rate (2015-2020) (US$ Million)
Figure 94. Latin America GABA (CAS 56-12-2) Market Share by Type in 2019
Figure 95. Latin America GABA (CAS 56-12-2) Market Share by Application in 2019
Figure 96. Middle East and Africa GABA (CAS 56-12-2) Sales Growth Rate 2015-2020 (K MT)
Figure 97. Middle East and Africa GABA (CAS 56-12-2) Revenue Growth Rate 2015-2020 (US$ Million)
Figure 98. Middle East and Africa GABA (CAS 56-12-2) Sales Market Share by Country in 2019
Figure 99. Middle East and Africa GABA (CAS 56-12-2) Revenue Market Share by Country in 2019
Figure 100. Turkey GABA (CAS 56-12-2) Sales Growth Rate (2015-2020) (K MT)
Figure 101. Turkey GABA (CAS 56-12-2) Revenue Growth Rate (2015-2020) (US$ Million)
Figure 102. Saudi Arabia GABA (CAS 56-12-2) Sales Growth Rate (2015-2020) (K MT)
Figure 103. Saudi Arabia GABA (CAS 56-12-2) Revenue Growth Rate (2015-2020) (US$ Million)
Figure 104. UAE GABA (CAS 56-12-2) Sales Growth Rate (2015-2020) (K MT)
Figure 105. UAE GABA (CAS 56-12-2) Revenue Growth Rate (2015-2020) (US$ Million)
Figure 106. Middle East and Africa GABA (CAS 56-12-2) Market Share by Type in 2019
Figure 107. Middle East and Africa GABA (CAS 56-12-2) Market Share by Application in 2019
Figure 108. Pharma Foods International Total Revenue (US$ Million): 2019 Compared with 2018
Figure 109. Sekisui Chemical Total Revenue (US$ Million): 2019 Compared with 2018
Figure 110. Zhejiang YiWan Biolabs Total Revenue (US$ Million): 2019 Compared with 2018
Figure 111. Shanghai Richen Total Revenue (US$ Million): 2019 Compared with 2018
Figure 112. Guangdong Luckerkong Biotech Total Revenue (US$ Million): 2019 Compared with 2018
Figure 113. Tianjin Shijitianlong Biotech Total Revenue (US$ Million): 2019 Compared with 2018
Figure 114. Ningxiang Jiayuan Biology Technology Total Revenue (US$ Million): 2019 Compared with 2018
Figure 115. Zhejiang Tianrui Chemical Total Revenue (US$ Million): 2019 Compared with 2018
Figure 116. Taizhou Xinyou Pharmaceutical & Chemical Total Revenue (US$ Million): 2019 Compared with 2018
Figure 117. North America GABA (CAS 56-12-2) Sales Growth Rate Forecast (2021-2026) (K MT)
Figure 118. North America GABA (CAS 56-12-2) Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 119. Europe GABA (CAS 56-12-2) Sales Growth Rate Forecast (2021-2026) (K MT)
Figure 120. Europe GABA (CAS 56-12-2) Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 121. Asia Pacific GABA (CAS 56-12-2) Sales Growth Rate Forecast (2021-2026) (K MT)
Figure 122. Asia Pacific GABA (CAS 56-12-2) Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 123. Latin America GABA (CAS 56-12-2) Sales Growth Rate Forecast (2021-2026) (K MT)
Figure 124. Latin America GABA (CAS 56-12-2) Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 125. Middle East and Africa GABA (CAS 56-12-2) Sales Growth Rate Forecast (2021-2026) (K MT)
Figure 126. Middle East and Africa GABA (CAS 56-12-2) Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 127. Porter's Five Forces Analysis
Figure 128. Channels of Distribution
Figure 129. Distributors Profiles
Figure 130. Bottom-up and Top-down Approaches for This Report
Figure 131. Data Triangulation
Figure 132. Key Executives Interviewed
